Geographic distribution of conversion therapy prevalence in Canada. Findings from a national cross-sectional survey, 2020.

Q2 Pharmacology, Toxicology and Pharmaceutics F1000Research Pub Date : 2024-08-15 eCollection Date: 2023-01-01 DOI:10.12688/f1000research.134292.1
Amrit Tiwana, Travis Salway, Julia Schillaci-Ventura, Sarah Watt
{"title":"Geographic distribution of conversion therapy prevalence in Canada. Findings from a national cross-sectional survey, 2020.","authors":"Amrit Tiwana, Travis Salway, Julia Schillaci-Ventura, Sarah Watt","doi":"10.12688/f1000research.134292.1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Conversion therapy practices (CTPs) are discredited efforts that target lesbian, gay, bisexual, trans, queer, Two-Spirit, or other (LGBTQ2S+) people and seek to change, deny, or discourage their sexual orientation, gender identity, and/or gender expression. This study aims to investigate the prevalence of CTPs across Canadian provinces and territories and identify whether CTP bans reduce the prevalence of CTPs.</p><p><strong>Methods: </strong>We collected 119 CTPs from 31 adults (18+) in Canada who have direct experience with CTPs, know people who have gone to CTPs, or know of conversion therapy practitioners using a 2020 anonymous online survey. Mapping analysis was conducted using ArcGIS Online. CTP prevalence was compared between provinces/territories with and without bans using chi-square tests.</p><p><strong>Results: </strong>Three provinces and eleven municipalities had CTP bans. The prevalence of CTPs in provinces/territories with bans was 2.34 per 1,000,000 population (95% CI 1.65, 3.31). The prevalence of CTPs in provinces/territories without bans was 4.13 per 1,000,000 population (95% CI 3.32, 5.14). Accounting for the underlying population, provinces/territories with the highest prevalence of CTPs per 1,000,000 population were New Brunswick (6.69), Nova Scotia (6.50), and Saskatchewan (6.37).</p><p><strong>Conclusions: </strong>Findings suggest only 55% of Canadians were protected under CTP bans. The prevalence of CTPs in provinces/territories without bans was 1.76 times greater than provinces/territories with bans. CTPs are occurring in most provinces/territories, with higher prevalence in the west and the Atlantic. These findings and continued efforts to monitor CTP prevalence can help inform policymakers and legislators as society is increasingly acknowledging CTPs as a threat to the health and well-being of LGBTQ2S+ people.</p>","PeriodicalId":12260,"journal":{"name":"F1000Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10905130/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"F1000Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/f1000research.134292.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Conversion therapy practices (CTPs) are discredited efforts that target lesbian, gay, bisexual, trans, queer, Two-Spirit, or other (LGBTQ2S+) people and seek to change, deny, or discourage their sexual orientation, gender identity, and/or gender expression. This study aims to investigate the prevalence of CTPs across Canadian provinces and territories and identify whether CTP bans reduce the prevalence of CTPs.

Methods: We collected 119 CTPs from 31 adults (18+) in Canada who have direct experience with CTPs, know people who have gone to CTPs, or know of conversion therapy practitioners using a 2020 anonymous online survey. Mapping analysis was conducted using ArcGIS Online. CTP prevalence was compared between provinces/territories with and without bans using chi-square tests.

Results: Three provinces and eleven municipalities had CTP bans. The prevalence of CTPs in provinces/territories with bans was 2.34 per 1,000,000 population (95% CI 1.65, 3.31). The prevalence of CTPs in provinces/territories without bans was 4.13 per 1,000,000 population (95% CI 3.32, 5.14). Accounting for the underlying population, provinces/territories with the highest prevalence of CTPs per 1,000,000 population were New Brunswick (6.69), Nova Scotia (6.50), and Saskatchewan (6.37).

Conclusions: Findings suggest only 55% of Canadians were protected under CTP bans. The prevalence of CTPs in provinces/territories without bans was 1.76 times greater than provinces/territories with bans. CTPs are occurring in most provinces/territories, with higher prevalence in the west and the Atlantic. These findings and continued efforts to monitor CTP prevalence can help inform policymakers and legislators as society is increasingly acknowledging CTPs as a threat to the health and well-being of LGBTQ2S+ people.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
加拿大转换疗法流行率的地理分布。2020 年全国横断面调查的结果。
背景:转化治疗法(CTPs)是一种不被认可的治疗方法,它针对女同性恋、男同性恋、双性恋、变性人、同性恋者、双灵者或其他(LGBTQ2S+)人群,试图改变、否认或阻止他们的性取向、性别认同和/或性别表达。本研究旨在调查加拿大各省和地区 CTP 的流行情况,并确定 CTP 禁令是否会降低 CTP 的流行率:我们采用 2020 年匿名在线调查的方式,从加拿大 31 名成年人(18 岁以上)中收集了 119 项 CTP,这些成年人与 CTP 有直接接触,认识曾去 CTP 的人,或知道转换疗法从业者。使用 ArcGIS Online 进行了制图分析。使用卡方检验比较了有禁令的省/地区和无禁令的省/地区之间的 CTP 流行率:结果:有三个省和十一个市禁止 CTP。有禁令的省/地区的 CTP 感染率为每 100 万人口 2.34 例(95% CI 1.65,3.31)。在没有禁令的省/地区,CTP 的流行率为每 100 万人口 4.13 例(95% CI 3.32,5.14)。考虑到基本人口,每 100 万人口中 CTP 发生率最高的省/地区是新不伦瑞克省(6.69)、新斯科舍省(6.50)和萨斯喀彻温省(6.37):研究结果表明,只有 55% 的加拿大人受到 CTP 禁令的保护。没有禁令的省/地区的 CTP 发生率是有禁令的省/地区的 1.76 倍。大多数省/地区都出现了 CTP,西部和大西洋地区的发生率更高。随着社会日益认识到CTP对LGBTQ2S+人群的健康和福祉构成威胁,这些发现以及对CTP发生率的持续监测有助于为政策制定者和立法者提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
F1000Research
F1000Research Pharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
5.00
自引率
0.00%
发文量
1646
审稿时长
1 weeks
期刊介绍: F1000Research publishes articles and other research outputs reporting basic scientific, scholarly, translational and clinical research across the physical and life sciences, engineering, medicine, social sciences and humanities. F1000Research is a scholarly publication platform set up for the scientific, scholarly and medical research community; each article has at least one author who is a qualified researcher, scholar or clinician actively working in their speciality and who has made a key contribution to the article. Articles must be original (not duplications). All research is suitable irrespective of the perceived level of interest or novelty; we welcome confirmatory and negative results, as well as null studies. F1000Research publishes different type of research, including clinical trials, systematic reviews, software tools, method articles, and many others. Reviews and Opinion articles providing a balanced and comprehensive overview of the latest discoveries in a particular field, or presenting a personal perspective on recent developments, are also welcome. See the full list of article types we accept for more information.
期刊最新文献
Teaching critical thinking about health information and choices in secondary schools: human-centred design of digital resources. Socio-demographic analysis of destination selection factors for Himalayan Hill destinations. Case Report: Shewanella algae, a rare cause of osteosynthesis-associated infection. Factors affecting community ambulation post-stroke: a mapping review protocol. Poweromin X Ten, a polyherbal formulation improves male sexual function: In vivo and network pharmacology study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1